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ESNIP’s are EC-funded “co-ordination actions” 
Dec ‘00 – March ‘04 
269 984 € 
14 partners 
coördinator Guus Koch 
Jan ‘06 – March ‘09 
300 000 € 
11 partners 
coördinator Kristien Van Reeth 
Nov ‘10 – Nov ’13 
1 000 000 € 
23 partners 




Swine influenza situation in 1999 
• Antigenic drift in H3N2 SIVs from The Netherlands 
and Belgium reported by some researchers,       
not by others 
• Emergence of a novel H1N2 reassortant               
(with human-like HA) in the UK in 1994 
• Sudden change in SI epidemiology in the US in 1998:      
triple reassortant H3N2 viruses 
• Cases of H5 and H9 avian influenza humans in    
Hong Kong; growing concerns about potential role of 
pigs as intermediate hosts 
  
ESNIP1 - Major achievements 
  
1 Standardization of protocols for diagnosis 
 
1 Selection of reference virus strains, production of 
hyperimmune sera 
 
2 Establishment of a central virus bank and an 
electronic database 
 
3 Antigenic & genetic characterization of some recent 
isolates 
 
4 Preliminary picture of prevalence of different SIV 
subtypes in different countries 
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ESNIP2 
• 169 SIVs isolated (2006 to 2008) 
• H1N1, H3N2 and H1N2 in Belgium, 
Italy, Spain 
• No H3N2 in UK or France 
• 97% “prototype” European SIVs  
• only 5 “novel” reassortants  










Strong antigenic relationship between older human H1N1  
and H3N2 viruses (1980s) and current swine H1N2 and H3N2  
(common origin!), but not with more recent human viruses. 
ESNIP2 - Major achievements 
  
1 Antigenic and genetic characterization of a (limited) 
number of European SIVs 
 
2 Serological profile of fatteners in 80 farrow-to-finish 
herds (Belgium, France, Italy, Spain) to determine 
infection pattern 
 
3 M gene-targeted real time RT-PCR for SIV established 
 
4 Expansion of virus bank 
 
1 Serologic investigations to determine cross-reactivity 
between 2009 pH1N1 virus and existing European SIVs 
 
ESNIP3 – What next? 
1. Whole genome sequencing 
2. Antigenic mapping using cartography 
3. Virus bank will be made publicly 
available at end of project 
 
 
ESNIP3 - participants 
P1:     Veterinary Laboratories Agency (VLA) UK 
P2:     Ghent University (UGent) BELGIUM 
P3:     French Agency for Food, Environmental and Occupational Health (AFSSA) FRANCE 
P4:     Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna  
           (IZSLER) ITALY 
P5:     Technical University of Denmark DENMARK  
P6:     Panstwowy Instytut Weterynaryjny POLAND 
P7:     Laboratorio Central Veterinario-Sanidad Animal SPAIN 
P8:     IDT Biologika GmbH GERMANY 
P9:     Finnish Food Safety Authority EVIRA FINLAND 
P10:   Kimron Veterinary Institute ISRAEL 
P11:   Veterinary Diagnostic Directorate HUNGARY 
ESNIP3 - participants 
P12:   Central Veterinary Institute of Wageningen THE NETHERLANDS 
P13:   University of Thessaly GREECE 
P14:   Wellcome Trust Sanger Institute UK 
P15:   University of Cambridge UK   
P16:   University of Oxford UK  
P17:   Friedrich Loeffler Institute GERMANY 
P18:   Istituto Zooprofilattico Sperimentale dele Venezie ITALY 
P19:   St. Jude Children’s Research Hospital USA 
P20:   United States Department of Agriculture USA 
P21:   Harbin Veterinary Institute CHINA 
P22:   MERIAL, Virology Department (MERIAL) FRANCE 
P23:   Laboratorios HIPRA S.A. (HIPRA) SPAIN 
P24:   Animal Health Trust UK 
Challenges to surveillance 
• Difficult access to samples, passive >> active 
surveillance, fragmented data analysis 
 
• Standardization of protocols is a must 
 
• Resources and time 
 
• More international harmonization and 





Thanks to the European Commission 
 and all ESNIP partners 
